Cargando…

Correction: Imatinib Ameliorates Neuroinflammation in a Rat Model of Multiple Sclerosis by Enhancing Blood-Brain Barrier Integrity and by Modulating the Peripheral Immune Response

Detalles Bibliográficos
Autores principales:	Z. Adzemovic, Milena, Zeitelhofer, Manuel, Eriksson, Ulf, Olsson, Tomas, Nilsson, Ingrid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3735721/ http://dx.doi.org/10.1371/annotation/dd60f248-ca3f-4824-a3b4-c07aefb1c7c3

Ejemplares similares

Imatinib Ameliorates Neuroinflammation in a Rat Model of Multiple Sclerosis by Enhancing Blood-Brain Barrier Integrity and by Modulating the Peripheral Immune Response
por: Z. Adzemovic, Milena, et al.
Publicado: (2013)

Blocking PDGF-CC signaling ameliorates multiple sclerosis-like neuroinflammation by inhibiting disruption of the blood–brain barrier
por: Zeitelhofer, Manuel, et al.
Publicado: (2020)

Correction: Imatinib Ameliorates Neuroinflammation in a Rat Model of Multiple Sclerosis by Enhancing Blood-Brain Barrier Integrity and by Modulating the Peripheral Immune Response
Publicado: (2015)

Preclinical toxicological assessment of a novel monoclonal antibody targeting human platelet-derived growth factor CC (PDGF-CC) in PDGF-CC(hum) mice
por: Zeitelhofer, Manuel, et al.
Publicado: (2018)

Editorial: Neuropathology of Autoimmune Inflammatory Demyelination Disorders
por: Zeitelhofer, Manuel, et al.
Publicado: (2022)

Expression of Ccl11 Associates with Immune Response Modulation and Protection against Neuroinflammation in Rats
por: Adzemovic, Milena Z., et al.
Publicado: (2012)

Effect of Vitamin D on Experimental Autoimmune Neuroinflammation Is Dependent on Haplotypes Comprising Naturally Occurring Allelic Variants of CIITA (Mhc2ta)
por: Hochmeister, Sonja, et al.
Publicado: (2020)

The formation of a glial scar does not prohibit remyelination in an animal model of multiple sclerosis
por: Haindl, Michaela Tanja, et al.
Publicado: (2018)

C-type lectin receptors Mcl and Mincle control development of multiple sclerosis–like neuroinflammation
por: N’diaye, Marie, et al.
Publicado: (2020)

VEGF‐B signaling impairs endothelial glucose transcytosis by decreasing membrane cholesterol content
por: Moessinger, Christine, et al.
Publicado: (2020)

Identification of four novel T cell autoantigens and personal autoreactive profiles in multiple sclerosis
por: Bronge, Mattias, et al.
Publicado: (2022)

Imatinib Enhances Functional Outcome after Spinal Cord Injury
por: Abrams, Mathew B., et al.
Publicado: (2012)

Lipocalin-2 as an Infection-Related Biomarker to Predict Clinical Outcome in Ischemic Stroke
por: Hochmeister, Sonja, et al.
Publicado: (2016)

Fine-Mapping Resolves Eae23 into Two QTLs and Implicates ZEB1 as a Candidate Gene Regulating Experimental Neuroinflammation in Rat
por: Stridh, Pernilla, et al.
Publicado: (2010)

Correction: Exploiting the promiscuity of imatinib
por: Lee, Shun J, et al.
Publicado: (2010)

Correction to: Elevated microRNA-129-5p level ameliorates neuroinflammation and blood-spinal cord barrier damage after ischemia–reperfusion by inhibiting HMGB1 and the TLR3-cytokine pathway
por: Li, Xiao-Qian, et al.
Publicado: (2021)

Correction to: Mild endoplasmic reticulum stress ameliorates lipopolysaccharide-induced neuroinflammation and cognitive impairment via regulation of microglial polarization
por: Wang, Yi-wei, et al.
Publicado: (2020)

Correction: Derivation of Neural Stem Cells from Human Adult Peripheral CD34+ Cells for an Autologous Model of Neuroinflammation
Publicado: (2014)

Correction to: Proinflammatory Extracellular Vesicle-Mediated Signaling Contributes to the Induction of Neuroinflammation in Animal Models of Endotoxemia and Peripheral Surgical Stress
por: Fricke, F., et al.
Publicado: (2021)

Thrombolytic tPA-induced hemorrhagic transformation of ischemic stroke is mediated by PKCβ phosphorylation of occludin
por: Goncalves, Andreia, et al.
Publicado: (2022)

Peripheral loss of EphA4 ameliorates TBI-induced neuroinflammation and tissue damage
por: Kowalski, Elizabeth A., et al.
Publicado: (2019)

Serum biomarkers of neuroinflammation and blood-brain barrier leakage in amyotrophic lateral sclerosis
por: Cao, Maize C., et al.
Publicado: (2022)

Correction: Tumor Volume as an Alternative Response Measurement for Imatinib Treated GIST Patients
por: Schiavon, Gaia, et al.
Publicado: (2013)

Vitamin D—An Effective Antioxidant in an Animal Model of Progressive Multiple Sclerosis
por: Haindl, Michaela Tanja, et al.
Publicado: (2023)

Author Correction: Smoking induces DNA methylation changes in Multiple Sclerosis patients with exposure-response relationship
por: Marabita, Francesco, et al.
Publicado: (2018)

Correction: Formulation and In Vitro, In Vivo Evaluation of Effervescent Floating Sustained-Release Imatinib Mesylate Tablet
Publicado: (2022)

Correction: Schroyen et al. Neuroinflammation and Its Association with Cognition, Neuronal Markers and Peripheral Inflammation after Chemotherapy for Breast Cancer. Cancers 2021, 13, 4198
por: Schroyen, Gwen, et al.
Publicado: (2023)

Correction: Systemic Inflammation in Progressive Multiple Sclerosis Involves Follicular T-Helper, Th17- and Activated B-Cells and Correlates with Progression
por: Romme Christensen, Jeppe, et al.
Publicado: (2013)

Development of monoclonal anti-PDGF-CC antibodies as tools for investigating human tissue expression and for blocking PDGF-CC induced PDGFRα signalling in vivo
por: Li, Hong, et al.
Publicado: (2018)

Correction: Effect of antiretroviral treatment on blood-brain barrier integrity in HIV-1 infection
por: Anesten, Birgitta, et al.
Publicado: (2022)

Correction: P-Glycoprotein Acts as an Immunomodulator during Neuroinflammation
por: Kooij, Gijs, et al.
Publicado: (2010)

Author Correction: Multicellular 3D Neurovascular Unit Model for Assessing Hypoxia and Neuroinflammation Induced Blood-Brain Barrier Dysfunction
por: Nzou, Goodwell, et al.
Publicado: (2020)

Imatinib treatment reduces brain injury in a murine model of traumatic brain injury
por: Su, Enming J., et al.
Publicado: (2015)

Pioglitazone ameliorates the phenotype of a novel Parkinson’s disease mouse model by reducing neuroinflammation
por: Pinto, Milena, et al.
Publicado: (2016)

Correction: Real-Time Analysis of Imatinib- and Dasatinib-Induced Effects on Chronic Myelogenous Leukemia Cell Interaction with Fibronectin
Publicado: (2014)

Correction to: the disruption of mitochondrial axonal transport is an early event in neuroinflammation
por: Errea, Oihana, et al.
Publicado: (2017)

Intranasal Methylprednisolone Ameliorates Neuroinflammation Induced by Chronic Toluene Exposure
por: Giraldo-Velásquez, Manuel F., et al.
Publicado: (2022)

Peripheral neuropathy associated with imatinib therapy for chronic myeloid leukemia
por: Kavanagh, Simon, et al.
Publicado: (2018)

The Role of BDNF in Multiple Sclerosis Neuroinflammation
por: Nociti, Viviana, et al.
Publicado: (2023)

Correction: Imatinib and Nilotinib Reverse Multidrug Resistance in Cancer Cells by Inhibiting the Efflux Activity of the MRP7 (ABCC10)
por: Shen, Tong, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_0jrq7mv30fap87n2usc17iflq4